Simcere Pharmaceutical Group Ltd

Common Name
Simcere Pharmaceutical Group
Country
China (Mainland)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
6,584
Ticker
2096
Exchange
HONG KONG EXCHANGES AND CLEARING LTD
Description
Simcere Pharmaceutical Group Ltd. is a leading biopharmaceutical company specializing in the research, development, manufacturing, and marketing of pharmaceutical products. Its primary focus is on the...

Simcere Pharmaceutical Group's Climate Target Data Preview

As of 2023, Simcere Pharmaceutical Group has disclosed 1 climate targets aimed at reducing its greenhouse gas (GHG) emissions. These include 1 intensity-based target, signaling the company’s commitment to managing and lowering its carbon footprint over time. The targets span various emissions scopes and time horizons, offering insight into Simcere Pharmaceutical Group ’s climate strategy, ambition level, and alignment with global decarbonization goals.

Target TypeScope of TargetUnitTargetTarget Year
Intensity-based Target
Scope 1 - Total, Scope 2 - Total
Metric Tonnes of CO2 equivalent (mtCO2e) per Renminbi/Chinese Yuan (RMB) of Revenue
Copy restricted. Please purchase to unlock this data.
2025

This table provides a simplified preview of selected climate targets data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.

Insights into Simcere Pharmaceutical Group's Greenhouse Gas Emissions Pathways

As of 2023, Simcere Pharmaceutical Group has set greenhouse gas (GHG) emissions reduction targets that cover its operational emissions (Scope 1 and 2), but not its value chain emissions (Scope 3). This means its reduction efforts currently focus on direct and purchased energy emissions.

Does Simcere Pharmaceutical Group have a target to reduce the emissions from its operations?

As of 2023, Simcere Pharmaceutical Group has set a target to reduce its operational greenhouse gas (GHG) emissions, specifically those from Scope 1 and Scope 2 sources.

Simcere Pharmaceutical Group's most ambitious operational target is to reduce these emissions by 10% by 2025, compared to a baseline of 0 Metric Tonnes of CO2 equivalent (mtCO2e) per Renminbi/Chinese Yuan (RMB) of Revenue in 2020.

Simcere Pharmaceutical Group has already surpassed its operational emissions reduction target, with 2023 levels falling below the 2025 value, achieving its climate goal ahead of schedule.

Simcere Pharmaceutical Group's Operational (Scope 1+2) Emissions Pathway

20202023202500000Current (-31%)Target 2025 (-10%)
Want Full Access to Simcere Pharmaceutical Group's Climate Targets Dataset?
Sign Up